Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMcbride Regulatory News (MCB)

Share Price Information for Mcbride (MCB)

Share Price is delayed by 15 minutes
Get Live Data
146.80    0.60 (0.41%)
Bid:
144.20
Ask:
147.00
Spread: 2.80 (1.942%)
Market Cap: £250.83m
MCB Live PriceLast checked at - London Stock Exchange

Intraday Mcbride Share Chart

AGM Statement

20 Nov 2025 16:40

RNS Number : 4278I
McBride PLC
20 November 2025
 

20 November 2025

 

McBride plc

Result of Annual General Meeting

 

McBride plc (the 'Company') is pleased to announce that at its Annual General Meeting ('AGM') held earlier today, 20 November 2025, all the resolutions put to its shareholders were passed by the requisite majorities. Resolutions 1 to 13 were passed as ordinary resolutions and resolutions 14 to 17 were passed as special resolutions.

 

The results of the poll vote for each resolution are set out below:

 

No 

RESOLUTION

VOTESFOR (incl. discretionary)

FOR (% of votes cast)

VOTESAGAINST

AGAINST (% of votes cast)

TOTAL VOTES CAST

% of ISSUED SHARE CAPITAL  VOTED

VOTESWITHHELD

1

To receive the Company's accounts for the financial year ended 30 June 2025, together with the Directors' reports and the independent auditor's report on those accounts.

85,390,995

99.99%

6,407

0.01%

85,397,402

47.84%

192,027

2

To approve the Directors' Remuneration Report for the financial year ended 30 June 2025 (other than the summary of the Directors' Remuneration Policy included in the Directors' Remuneration Report)

85,260,889

99.64%

310,662

0.36%

85,571,551

47.93%

17,878

3

To declare a final dividend of 3.0 pence per ordinary share in respect of the year ended 30 June 2025.

85,573,374

100.00%

49

0.00%

85,573,423

47.94%

16,006

4

To re‑appoint Jeffrey (Jeff) Nodland as a Director.

81,458,624

95.20%

4,106,496

4.80%

85,565,120

47.93%

24,309

5

To re‑appoint Christopher (Chris) Smith as a Director.

84,087,237

99.95%

42,722

0.05%

84,129,959

47.13%

1,459,470

6

To re-appoint Mark Strickland as a Director.

85,525,958

99.95%

39,162

0.05%

85,565,120

47.93%

24,309

7

To re-appoint Elizabeth (Liz) McMeikan as a Director.

82,486,730

96.40%

3,078,390

3.60%

85,565,120

47.93%

24,309

8

To re-appoint Alastair Murray as a Director.

83,074,042

97.09%

2,491,078

2.91%

85,565,120

47.93%

24,309

9

To re-appoint Regi Aalstad as a Director.

84,387,739

98.68%

1,126,881

1.32%

85,514,620

47.90%

74,809

10

To re-appoint PricewaterhouseCoopers LLP as auditor of the Company.

84,841,426

99.16%

719,871

0.84%

85,561,297

47.93%

28,132

11

To authorise the Audit and Risk Committee to determine the auditor's remuneration.

84,948,619

99.27%

624,153

0.73%

85,572,772

47.94%

16,657

12

To authorise the Company and its subsidiaries to make political donations and incur political expenditure

85,418,741

99.82%

153,461

0.18%

85,572,202

47.93%

17,227

13

To authorise the Directors to allot shares.

85,523,469

99.94%

48,303

0.06%

85,571,772

47.93%

17,657

14

Subject to the passing of Resolution 13, to authorise the Directors to disapply statutory pre-emption rights in respect of the allotment of the Company's equity securities for cash.

85,457,676

99.88%

106,105

0.12%

85,563,781

47.93%

25,648

15

To authorise the Company to make market purchases of its own shares.

85,492,960

99.95%

42,854

0.05%

85,535,814

47.91%

53,615

16

To authorise the Directors to call a general meeting on 14 clear days' notice.

85,439,241

99.84%

133,531

0.16%

85,572,772

47.94%

16,657

17

To approve, amongst other things, the waiver and release of certain claims which the Company may have in relation to certain dividends and certain loans.

83,223,275

99.94%

52,288

0.06%

83,275,563

46.65%

2,312,085

 

 

The Board would like to thank shareholders for their engagement and support ahead of the AGM and throughout the year.

 

Notes:

 

1. Any proxy arrangement which gave discretion to the Chairman has been included in the "For" totals.

2. A "Vote withheld" is not a vote in law and is not counted in the calculation of the percentage of shares voted "For" or "Against" any resolution or the total number of votes cast.

3. On 19 November 2025, the Company's issued share capital comprised 178,517,862 ordinary shares of 10 pence each (excluding treasury shares), 42,041 ordinary shares of 10 pence each held in treasury ('treasury shares') and 665,888,258 non-cumulative redeemable preference shares of 0.1 pence each ('B shares'). Each ordinary share of the Company carries one vote at General Meetings of the Company. Any ordinary shares held in treasury and the B shares have no voting rights. Consequently, on 19 November 2025, the total number of voting rights was 178,517,862.

4. Pursuant to UK Listing Rule 6.4.2, copies of all resolutions, other than those concerning ordinary business, passed at the AGM today will be submitted to the National Storage Mechanism and will shortly be available to view at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

5. Results of the poll will also be available shortly to view on the Company's website at www.mcbride.co.uk/investors/shareholder-information/agm/.

 

 

 

For further enquiries:

McBride plc

Robert Henry, General Counsel and Company Secretary

Chris Smith, Chief Executive Officer

 

0161 203 7401

Instinctif Partners

Hannah Scott

Galyna Kulachek

0207 457 2020

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMFLFVRLALIFIE
Date   Source Headline
2nd May 20249:21 amRNSHolding(s) in Company
30th Apr 20247:00 amRNSTrading Update
8th Apr 202411:24 amRNSHolding(s) in Company
8th Apr 202411:22 amRNSHolding(s) in Company
5th Apr 20249:53 amRNSHolding(s) in Company
28th Mar 20243:20 pmRNSDirector/PDMR Shareholding
25th Mar 20241:52 pmRNSDirector/PDMR Shareholding
13th Mar 20247:00 amRNSCapital Markets Day
28th Feb 20242:30 pmRNSDirector/PDMR Shareholding
27th Feb 20247:00 amRNSHalf-year Report
16th Jan 20247:00 amRNSTrading Update
13th Dec 20231:47 pmRNSDirector/PDMR Shareholding
20th Nov 20235:55 pmRNSDirector/PDMR Shareholding
20th Nov 20235:39 pmRNSResult of AGM
20th Nov 20237:00 amRNSAGM Trading Update
25th Oct 202310:22 amRNSTermination of ‘upside sharing’ mechanism
19th Oct 20237:00 amRNSTrading Update
17th Oct 20235:42 pmRNSPosting of ARA and Notice of AGM
4th Oct 20235:24 pmRNSVesting of RSU Awards
29th Sep 20237:00 amRNSDirector/PDMR Shareholding
22nd Sep 20235:33 pmRNSDirector/PDMR Shareholding
21st Sep 202310:54 amRNSDirector/PDMR Shareholding
19th Sep 20237:00 amRNSFinal Results
14th Jul 20237:00 amRNSFull year trading update
13th Jun 20237:00 amRNSDirector/PDMR Shareholding
31st May 20235:31 pmRNSDirectorate Change
25th May 20239:38 amRNSDirector Declaration
2nd May 20237:00 amRNSDirector/PDMR Shareholding
25th Apr 20237:00 amRNSTrading Update
11th Apr 20232:08 pmRNSDirector/PDMR Shareholding
3rd Apr 20232:39 pmRNSDirector/PDMR Shareholding
31st Mar 202312:27 pmRNSDirector/PDMR Shareholding
21st Mar 20235:59 pmRNSDirector/PDMR Shareholding
28th Feb 20237:00 amRNSHalf-year Report
1st Feb 20234:40 pmRNSSecond Price Monitoring Extn
1st Feb 20234:35 pmRNSPrice Monitoring Extension
1st Feb 20238:46 amRNSDirector Declaration
17th Jan 20237:00 amRNSTrading Update
11th Jan 20239:01 amRNSDirector Declaration
22nd Dec 20224:23 pmRNSDirector/PDMR Shareholding
13th Dec 20222:51 pmRNSDirector/PDMR Shareholding
16th Nov 20224:42 pmRNSAGM Statement
16th Nov 20227:00 amRNSAGM Trading Update
17th Oct 20227:00 amRNSAnnual Report 2022 and Annual General Meeting 2022
5th Oct 20225:55 pmRNSDirector/PDMR Shareholding
3rd Oct 20225:07 pmRNSRedemption of B Shares
29th Sep 202212:49 pmRNSFinal Results
29th Sep 202211:51 amRNSAmended Financing Agreement
29th Sep 20227:00 amRNSPreliminary results timing
6th Sep 20222:51 pmRNSBoard Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.